EntryPoint Capital »

Compass Therapeutics shares owned by EntryPoint Capital

Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by EntryPoint Capital from 13F filings

Historical chart of EntryPoint Capital investment in Compass Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Compass Therapeutics held by EntryPoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Therapeutics by EntryPoint Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $71k 13k 5.37

More positions owned by EntryPoint Capital

Charles Schwab Corporation (SCHW)
PNC Financial Services (PNC)
Ameriprise Financial (AMP)
Target Corporation (TGT)
Ares Management Corporation Cl A Com Stk (ARES)
UMH Properties (UMH)
Vici Pptys (VICI)
TJX Companies (TJX)
Service Corporation International (SCI)
Zoetis Cl A (ZTS)
Honeywell International (HON)
State Street Corporation (STT)
Marsh & McLennan Companies
News Corp Cl A (NWSA)
RBC Bearings Incorporated (RBC)

View all positions for EntryPoint Capital

Top funds holding Compass Therapeutics

Tang Capital Management
OrbiMed Advisors
Suvretta Capital Management
Blackstone Group
Vivo Capital
BlackRock
Vanguard Group
Enavate Sciences GP
Adage Capital Partners GP
State Street Corporation
BVF
FMR
Rock Springs Capital Management
Deerfield Management Company
Geode Capital Management

View all funds holding Compass Therapeutics